News from Decision Resources, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 05, 2013, 13:04 ET Surveyed Oncologists Indicate that the Use of Biomarker Testing is Increasing Rapidly in Non-Small-Cell Lung Cancer in China and South Korea

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the...


Dec 05, 2013, 09:00 ET Approval of Stelara for Psoriatic Arthritis and for Self-Administration is Likely to Help the Drug's Uptake in the Psoriasis Market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that—following...


Dec 05, 2013, 08:00 ET The Approval Of The First Biosimilar Monoclonal Antibody In Europe Has Major Implications For 2014 And Beyond

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, identifies key clinical,...


Dec 04, 2013, 09:30 ET Sales of Antiretroviral Drugs for HIV Will Decrease Marginally Over the Next Decade, from an Estimated $13.4 Billion in 2012 to $13.1 Billion in 2022

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that major-market...


Dec 04, 2013, 09:00 ET Despite Coverage of All Biologics in the Public Sector, Differences in Healthcare Provision Between States in Brazil is Limiting Access to Biologic Treatment for Rheumatoid Arthritis

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the National...


Dec 04, 2013, 08:00 ET Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next...


Dec 03, 2013, 11:15 ET The U.S. Market for Predictive Personalized Drugs Will Double from 2013 until 2019

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the U.S....


Dec 03, 2013, 09:00 ET Increasing Use of Allergan's Botox and the Launch of Novel Nontriptan Products Will Be Key Drivers of Migraine Market Growth Through 2022

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the use of...


Dec 02, 2013, 08:00 ET Pharma Should Factor Medication Adherence Into Drug Development

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in response to...


Nov 26, 2013, 09:00 ET Surveyed Endocrinologists Consider Eli Lilly's Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, among a...


Nov 26, 2013, 09:00 ET Close To 50 Percent Of Drug-Treated Major Depressive Disorder Patients Progress To Second-Line Therapies Within One Year Of Diagnosis

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through...


Nov 25, 2013, 12:05 ET Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in China, a...


Nov 25, 2013, 09:00 ET Disease and Prescription Drug Information are the Most Common Search Topics for Online Baby Boomers Looking for Health Information

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority...


Nov 21, 2013, 10:00 ET Oncology is the Most Active Therapeutic Area for Phase II/III R&D

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while metabolic...


Nov 20, 2013, 09:00 ET U.S. Claims Data Show Declining Use of Platform Injectables as Oral Multiple Sclerosis Therapies Gain Traction

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through...


Nov 19, 2013, 09:00 ET Current MRSA Antibiotics Will Face Competition from Durata's Dalbavancin and The Medicines Company's Oritavancin for Use in the Outpatient Setting

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than...


Nov 18, 2013, 09:00 ET Managed Care Plans, Patients Become Bigger Influencers in Physician Prescribing

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds prescribing...


Nov 14, 2013, 10:00 ET U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVie's Humira, as a Result of Its Recent Approval in Ulcerative Colitis

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that through...


Nov 14, 2013, 09:00 ET Surveyed EU5 Rheumatologists Prescribe Biologics to Approximately Half of Their DMARD-Treated Psoriatic Arthritis Patients

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed...


Nov 13, 2013, 09:00 ET Ultra-Orphan Drug Specialists Represent Poor Value for Money as M&A Targets

 Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that...